Risk factor
Low price volatility
Resilient to price shocks
Poor trading liquidity
Profitability factor
Very strong margins and returns
Favourable analyst view
Slightly overvalued vs peers
Risk / Profitability
Risk: Limited
Profitability: Favourable
Risk factor
Low price volatility
Resilient to price shocks
Poor trading liquidity
Profitability factor
Very strong margins and returns
Favourable analyst view
Slightly overvalued vs peers
€ 46.85
About
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active...
About
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL...
